Decreased CD27 on B Lymphocytes in Patients with Primary Hepatocellular Carcinoma.

X. D. Wang,L. Wang,F. J. Ji,J. M. Zhu,D. A. Ayana,X. D. Fang
DOI: https://doi.org/10.1177/147323001204000131
2012-01-01
Journal of International Medical Research
Abstract:OBJECTIVES: Hepatitis B virus (HBV) replicates in the liver and can lead to hepatocellular carcinoma (HCC). The B lymphocytes may provide a means for HBV to persist although the mechanism remains unknown. This study aimed to characterize B lymphocyte subset phenotypes and measure levels of B lymphocyte-related cytokines in HCC patients. METHODS: The study population included 38 HCC patients and 30 healthy control subjects. Phenotyping of B lymphocytes was performed by flow cytometry. Serum cytokine levels were measured using a cytometric bead array immunoassay. RESULTS: The ratio of naIve (CD29(+)CD27(-)) to memory (CD19(+)CD27(+)) B lymphocytes was significantly higher in HCC patients compared with healthy controls. The percentage of memory B lymphocytes decreased with the progression of HCC. Levels of interleukin (IL)-6 and IL-10 were significantly increased in HCC patients compared with healthy controls. CONCLUSIONS: The depletion of memory B lymphocytes may contribute to unresponsiveness to HBV or to HCC. This humoral defect might be related to raised production of IL-6 and IL-10.
What problem does this paper attempt to address?